Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 7.11785500 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 7.11785500 |
3 | nuclear pore complex assembly (GO:0051292) | 5.95646044 |
4 | nuclear pore organization (GO:0006999) | 5.45209135 |
5 | COPII vesicle coating (GO:0048208) | 5.27186226 |
6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.93164252 |
7 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.85363558 |
8 | muscle filament sliding (GO:0030049) | 4.82138514 |
9 | actin-myosin filament sliding (GO:0033275) | 4.82138514 |
10 | positive regulation of nuclease activity (GO:0032075) | 4.59492427 |
11 | paraxial mesoderm development (GO:0048339) | 4.51895281 |
12 | actin-mediated cell contraction (GO:0070252) | 4.33872201 |
13 | protein retention in ER lumen (GO:0006621) | 4.28469304 |
14 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.27377232 |
15 | mitotic sister chromatid cohesion (GO:0007064) | 4.26970049 |
16 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.19258110 |
17 | regulation of nuclease activity (GO:0032069) | 4.15546315 |
18 | pore complex assembly (GO:0046931) | 4.06627295 |
19 | IMP metabolic process (GO:0046040) | 4.04858938 |
20 | cellular response to unfolded protein (GO:0034620) | 4.03055034 |
21 | vesicle coating (GO:0006901) | 3.99980553 |
22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.99540757 |
23 | L-phenylalanine catabolic process (GO:0006559) | 3.99540757 |
24 | intestinal cholesterol absorption (GO:0030299) | 3.97217806 |
25 | ER-nucleus signaling pathway (GO:0006984) | 3.97107552 |
26 | establishment of integrated proviral latency (GO:0075713) | 3.77973968 |
27 | regulation of cholesterol homeostasis (GO:2000188) | 3.76940463 |
28 | cellular response to topologically incorrect protein (GO:0035967) | 3.73875690 |
29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.72585353 |
30 | L-phenylalanine metabolic process (GO:0006558) | 3.72585353 |
31 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.70962665 |
32 | pre-miRNA processing (GO:0031054) | 3.68037763 |
33 | 4-hydroxyproline metabolic process (GO:0019471) | 3.67324235 |
34 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.67099669 |
35 | protein carboxylation (GO:0018214) | 3.65601086 |
36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.65601086 |
37 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.62374164 |
38 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.61487811 |
39 | IMP biosynthetic process (GO:0006188) | 3.58180338 |
40 | intestinal absorption (GO:0050892) | 3.57665411 |
41 | alpha-linolenic acid metabolic process (GO:0036109) | 3.47820853 |
42 | actin filament-based movement (GO:0030048) | 3.45735854 |
43 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.44408071 |
44 | macroautophagy (GO:0016236) | 3.42908787 |
45 | response to endoplasmic reticulum stress (GO:0034976) | 3.39947422 |
46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37207253 |
47 | lysine catabolic process (GO:0006554) | 3.35200394 |
48 | lysine metabolic process (GO:0006553) | 3.35200394 |
49 | sulfur amino acid catabolic process (GO:0000098) | 3.34361547 |
50 | regulation of gene silencing by RNA (GO:0060966) | 3.32023468 |
51 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.32023468 |
52 | regulation of gene silencing by miRNA (GO:0060964) | 3.32023468 |
53 | skeletal muscle contraction (GO:0003009) | 3.30958809 |
54 | cysteine metabolic process (GO:0006534) | 3.30020035 |
55 | negative regulation of fibrinolysis (GO:0051918) | 3.29680130 |
56 | negative regulation of DNA repair (GO:0045738) | 3.28410222 |
57 | regulation of RNA export from nucleus (GO:0046831) | 3.25380088 |
58 | DNA unwinding involved in DNA replication (GO:0006268) | 3.24799486 |
59 | protein complex localization (GO:0031503) | 3.23753017 |
60 | aromatic amino acid family catabolic process (GO:0009074) | 3.22607989 |
61 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.19133067 |
62 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.18578435 |
63 | synapsis (GO:0007129) | 3.17570655 |
64 | regulation of translational fidelity (GO:0006450) | 3.14431922 |
65 | endocrine pancreas development (GO:0031018) | 3.13482964 |
66 | type B pancreatic cell development (GO:0003323) | 3.12844628 |
67 | complement activation, alternative pathway (GO:0006957) | 3.12659437 |
68 | cellular protein complex localization (GO:0034629) | 3.10878326 |
69 | response to unfolded protein (GO:0006986) | 3.10735030 |
70 | anterior/posterior axis specification, embryo (GO:0008595) | 3.08618888 |
71 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.07160656 |
72 | protein localization to kinetochore (GO:0034501) | 3.07000851 |
73 | valine metabolic process (GO:0006573) | 3.06092944 |
74 | regulation of histone H3-K9 methylation (GO:0051570) | 3.05330146 |
75 | ribosome assembly (GO:0042255) | 3.03596720 |
76 | high-density lipoprotein particle remodeling (GO:0034375) | 3.00395567 |
77 | urea cycle (GO:0000050) | 2.99596515 |
78 | urea metabolic process (GO:0019627) | 2.99596515 |
79 | low-density lipoprotein particle clearance (GO:0034383) | 2.98357988 |
80 | exocrine pancreas development (GO:0031017) | 2.98181302 |
81 | hormone catabolic process (GO:0042447) | 2.97456400 |
82 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.95867872 |
83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.95591828 |
84 | response to topologically incorrect protein (GO:0035966) | 2.94658340 |
85 | sarcomere organization (GO:0045214) | 2.94352033 |
86 | myofibril assembly (GO:0030239) | 2.93955585 |
87 | mitotic metaphase plate congression (GO:0007080) | 2.92940972 |
88 | ER overload response (GO:0006983) | 2.91731992 |
89 | formation of translation preinitiation complex (GO:0001731) | 2.91438943 |
90 | response to muscle activity (GO:0014850) | 2.90996154 |
91 | heterochromatin organization (GO:0070828) | 2.89964912 |
92 | Golgi organization (GO:0007030) | 2.89573187 |
93 | reverse cholesterol transport (GO:0043691) | 2.89306464 |
94 | NLS-bearing protein import into nucleus (GO:0006607) | 2.88754205 |
95 | regulation of protein activation cascade (GO:2000257) | 2.87188135 |
96 | kynurenine metabolic process (GO:0070189) | 2.86280864 |
97 | mitotic chromosome condensation (GO:0007076) | 2.85154553 |
98 | protein maturation by protein folding (GO:0022417) | 2.84355931 |
99 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.83736279 |
100 | regulation of fibrinolysis (GO:0051917) | 2.83500204 |
101 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.82945739 |
102 | homocysteine metabolic process (GO:0050667) | 2.82540645 |
103 | gap junction assembly (GO:0016264) | 2.82206489 |
104 | protein localization to chromosome, centromeric region (GO:0071459) | 2.80693426 |
105 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.80306325 |
106 | cardiac myofibril assembly (GO:0055003) | 2.78931098 |
107 | cellular modified amino acid catabolic process (GO:0042219) | 2.78368906 |
108 | plasma lipoprotein particle clearance (GO:0034381) | 2.78124012 |
109 | peptide hormone processing (GO:0016486) | 2.77976937 |
110 | plasma membrane repair (GO:0001778) | 2.74850728 |
111 | apoptotic cell clearance (GO:0043277) | 2.74407900 |
112 | notochord development (GO:0030903) | 2.74184669 |
113 | regulation of complement activation (GO:0030449) | 2.73233192 |
114 | positive regulation of catenin import into nucleus (GO:0035413) | 2.72029537 |
115 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.72000510 |
116 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.71244445 |
117 | sequestering of metal ion (GO:0051238) | 2.70666392 |
118 | hippo signaling (GO:0035329) | 2.70632736 |
119 | triglyceride homeostasis (GO:0070328) | 2.70363847 |
120 | acylglycerol homeostasis (GO:0055090) | 2.70363847 |
121 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.69070856 |
122 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.67689459 |
123 | regulation of cell fate specification (GO:0042659) | 2.67409206 |
124 | glandular epithelial cell development (GO:0002068) | 2.67177938 |
125 | bile acid biosynthetic process (GO:0006699) | 2.67095964 |
126 | positive regulation of glycolytic process (GO:0045821) | 2.66938274 |
127 | endoplasmic reticulum organization (GO:0007029) | 2.66634457 |
128 | lipoprotein metabolic process (GO:0042157) | 2.66552280 |
129 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.66431494 |
130 | positive regulation of p38MAPK cascade (GO:1900745) | 2.65939683 |
131 | nitrogen cycle metabolic process (GO:0071941) | 2.65241329 |
132 | tricarboxylic acid metabolic process (GO:0072350) | 2.65169544 |
133 | negative regulation of sterol transport (GO:0032372) | 2.64597646 |
134 | negative regulation of cholesterol transport (GO:0032375) | 2.64597646 |
135 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.62826510 |
136 | positive regulation of histone deacetylation (GO:0031065) | 2.62544844 |
137 | tryptophan metabolic process (GO:0006568) | 2.62153744 |
138 | protein targeting to Golgi (GO:0000042) | 2.61084860 |
139 | phospholipid homeostasis (GO:0055091) | 2.61061003 |
140 | establishment of viral latency (GO:0019043) | 2.60007670 |
141 | regulation of triglyceride catabolic process (GO:0010896) | 2.59948264 |
142 | positive regulation of chromosome segregation (GO:0051984) | 2.58722027 |
143 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.58620451 |
144 | non-recombinational repair (GO:0000726) | 2.58620451 |
145 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.58484599 |
146 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.57636029 |
147 | negative regulation of sister chromatid segregation (GO:0033046) | 2.57636029 |
148 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.57636029 |
149 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.57636029 |
150 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.57636029 |
151 | actomyosin structure organization (GO:0031032) | 2.57559997 |
152 | glyoxylate metabolic process (GO:0046487) | 2.56569469 |
153 | negative regulation of lipid transport (GO:0032369) | 2.56453279 |
154 | metaphase plate congression (GO:0051310) | 2.56447071 |
155 | glutamate metabolic process (GO:0006536) | 2.56151306 |
156 | drug transmembrane transport (GO:0006855) | 2.56105396 |
157 | 2-oxoglutarate metabolic process (GO:0006103) | 2.55893909 |
158 | tryptophan catabolic process (GO:0006569) | 2.55167859 |
159 | indole-containing compound catabolic process (GO:0042436) | 2.55167859 |
160 | indolalkylamine catabolic process (GO:0046218) | 2.55167859 |
161 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.55166368 |
162 | phospholipid efflux (GO:0033700) | 2.54701709 |
163 | plasma lipoprotein particle remodeling (GO:0034369) | 2.54333777 |
164 | protein-lipid complex remodeling (GO:0034368) | 2.54333777 |
165 | macromolecular complex remodeling (GO:0034367) | 2.54333777 |
166 | protein localization to endosome (GO:0036010) | 2.54216284 |
167 | tricarboxylic acid cycle (GO:0006099) | 2.54123259 |
168 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.53960850 |
169 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.53960850 |
170 | regulation of helicase activity (GO:0051095) | 2.53012397 |
171 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.50756499 |
172 | negative regulation of chromosome segregation (GO:0051985) | 2.50321046 |
173 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.46007893 |
174 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.46007893 |
175 | regulation of sister chromatid segregation (GO:0033045) | 2.46007893 |
176 | regulation of chromosome segregation (GO:0051983) | 2.43440448 |
177 | NADH metabolic process (GO:0006734) | 2.39199806 |
178 | mitotic spindle checkpoint (GO:0071174) | 2.38980201 |
179 | DNA synthesis involved in DNA repair (GO:0000731) | 2.38343426 |
180 | hemidesmosome assembly (GO:0031581) | 2.38147559 |
181 | response to X-ray (GO:0010165) | 2.37824852 |
182 | glycogen catabolic process (GO:0005980) | 2.37319876 |
183 | glucan biosynthetic process (GO:0009250) | 2.37270694 |
184 | glycogen biosynthetic process (GO:0005978) | 2.37270694 |
185 | AMP metabolic process (GO:0046033) | 2.35721590 |
186 | cell adhesion mediated by integrin (GO:0033627) | 2.35370275 |
187 | regulation of sister chromatid cohesion (GO:0007063) | 2.35251363 |
188 | glutamine metabolic process (GO:0006541) | 2.34747583 |
189 | striated muscle contraction (GO:0006941) | 2.32600809 |
190 | mitotic nuclear envelope disassembly (GO:0007077) | 2.32073763 |
191 | regulation of coenzyme metabolic process (GO:0051196) | 2.31973076 |
192 | regulation of cofactor metabolic process (GO:0051193) | 2.31973076 |
193 | spindle checkpoint (GO:0031577) | 2.31752888 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.18985363 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.05846136 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.73119352 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18876552 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.17893095 |
6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.37289507 |
7 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.26242078 |
8 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 3.24533272 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.06973859 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.04243852 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.98186766 |
12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.76767218 |
13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.73304295 |
14 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.72585851 |
15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.66337346 |
16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.64471878 |
17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.50467264 |
18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.43905379 |
19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.37216854 |
20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.30271568 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16685432 |
22 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.10528457 |
23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.10028785 |
24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08636398 |
25 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 2.06276389 |
26 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.05657246 |
27 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.05657246 |
28 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.05657246 |
29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.98059421 |
30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.95465307 |
31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.95442185 |
32 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.94918958 |
33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.94894406 |
34 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.88318978 |
35 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.85009281 |
36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.81900475 |
37 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.81529195 |
38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80651040 |
39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77962894 |
40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.74354260 |
41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65910398 |
42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.65744320 |
43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.64723642 |
44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64194807 |
45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.62357479 |
46 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58778916 |
47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.57472761 |
48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.57053443 |
49 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.56130925 |
50 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.54458448 |
51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52720006 |
52 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.52148502 |
53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52008079 |
54 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.49105262 |
55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.48107028 |
56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46864845 |
57 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.45400679 |
58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45306109 |
59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45279280 |
60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.43258353 |
61 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40854949 |
62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.39280857 |
63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38995148 |
64 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.38704462 |
65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37491976 |
66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37344096 |
67 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.35900959 |
68 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.35839422 |
69 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34473919 |
70 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33129745 |
71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.30807115 |
72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28542738 |
73 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.28288098 |
74 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28148682 |
75 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28131216 |
76 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.27999053 |
77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27793157 |
78 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.26714928 |
79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26216681 |
80 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25936720 |
81 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24810208 |
82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24110277 |
83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23370046 |
84 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.23230349 |
85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22967061 |
86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20497797 |
87 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.20224795 |
88 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.19740935 |
89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19728154 |
90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.19569748 |
91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.19569748 |
92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19067294 |
93 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18480553 |
94 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17260073 |
95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16960908 |
96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16396123 |
97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.16208135 |
98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15993079 |
99 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15908687 |
100 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15769425 |
101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14460516 |
102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14460516 |
103 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13977407 |
104 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13010581 |
105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12933188 |
106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12933188 |
107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12860684 |
108 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12845381 |
109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12671832 |
110 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.12412712 |
111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11738862 |
112 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11451182 |
113 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.10770657 |
114 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10175638 |
115 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07142385 |
116 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.06901200 |
117 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06697879 |
118 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06529977 |
119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06285344 |
120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06081560 |
121 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.05553226 |
122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04904627 |
123 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04781697 |
124 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04373561 |
125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04228316 |
126 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03784376 |
127 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03738997 |
128 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.02952690 |
129 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02273519 |
130 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.01953188 |
131 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01903782 |
132 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01880241 |
133 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01601944 |
134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01111243 |
135 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01033064 |
136 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01003597 |
137 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00881313 |
138 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00526671 |
139 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.00506509 |
140 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00070345 |
141 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99287927 |
142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98735607 |
143 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98199215 |
144 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97848601 |
145 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95898728 |
146 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93938504 |
147 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93715282 |
148 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93443504 |
149 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.93350194 |
150 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.90958248 |
151 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.90675592 |
152 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89450011 |
153 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89327451 |
154 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88305136 |
155 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.86423866 |
156 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86386386 |
157 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86333243 |
158 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85923558 |
159 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84284072 |
160 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84244906 |
161 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.84015773 |
162 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83923115 |
163 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.83698361 |
164 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83184605 |
165 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83136305 |
166 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82272318 |
167 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81963097 |
168 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79412878 |
169 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79393467 |
170 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.78921699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003941_abnormal_skin_development | 4.81182071 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.76188369 |
3 | MP0005365_abnormal_bile_salt | 3.77129261 |
4 | MP0005360_urolithiasis | 3.73967224 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.43416604 |
6 | MP0002877_abnormal_melanocyte_morpholog | 3.36622161 |
7 | MP0003705_abnormal_hypodermis_morpholog | 3.32168291 |
8 | MP0003252_abnormal_bile_duct | 3.22554256 |
9 | MP0003195_calcinosis | 2.79129615 |
10 | MP0009780_abnormal_chondrocyte_physiolo | 2.76277005 |
11 | MP0000751_myopathy | 2.71802548 |
12 | MP0003300_gastrointestinal_ulcer | 2.61015168 |
13 | MP0001666_abnormal_nutrient_absorption | 2.38837450 |
14 | MP0004233_abnormal_muscle_weight | 2.37466873 |
15 | MP0004957_abnormal_blastocyst_morpholog | 2.33579870 |
16 | MP0010234_abnormal_vibrissa_follicle | 2.31936025 |
17 | MP0000749_muscle_degeneration | 2.31172477 |
18 | MP0004084_abnormal_cardiac_muscle | 2.31000935 |
19 | MP0005451_abnormal_body_composition | 2.30513134 |
20 | MP0004036_abnormal_muscle_relaxation | 2.29818847 |
21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.24143320 |
22 | MP0005083_abnormal_biliary_tract | 2.23968911 |
23 | MP0008057_abnormal_DNA_replication | 2.19686680 |
24 | MP0002909_abnormal_adrenal_gland | 2.18037385 |
25 | MP0004264_abnormal_extraembryonic_tissu | 2.17542716 |
26 | MP0010329_abnormal_lipoprotein_level | 2.13527302 |
27 | MP0002254_reproductive_system_inflammat | 2.09307472 |
28 | MP0000013_abnormal_adipose_tissue | 2.03603202 |
29 | MP0003950_abnormal_plasma_membrane | 2.02161117 |
30 | MP0003646_muscle_fatigue | 2.01490177 |
31 | MP0001944_abnormal_pancreas_morphology | 1.98687192 |
32 | MP0004145_abnormal_muscle_electrophysio | 1.97725106 |
33 | MP0003283_abnormal_digestive_organ | 1.97328073 |
34 | MP0004043_abnormal_pH_regulation | 1.91429780 |
35 | MP0009840_abnormal_foam_cell | 1.88747805 |
36 | MP0002693_abnormal_pancreas_physiology | 1.87747332 |
37 | MP0003890_abnormal_embryonic-extraembry | 1.82580425 |
38 | MP0001661_extended_life_span | 1.82109647 |
39 | MP0005220_abnormal_exocrine_pancreas | 1.81244131 |
40 | MP0003806_abnormal_nucleotide_metabolis | 1.79456946 |
41 | MP0003868_abnormal_feces_composition | 1.75939330 |
42 | MP0008438_abnormal_cutaneous_collagen | 1.73057907 |
43 | MP0003693_abnormal_embryo_hatching | 1.69728481 |
44 | MP0000003_abnormal_adipose_tissue | 1.67585617 |
45 | MP0009697_abnormal_copulation | 1.64085386 |
46 | MP0005330_cardiomyopathy | 1.62380863 |
47 | MP0005076_abnormal_cell_differentiation | 1.61779658 |
48 | MP0000609_abnormal_liver_physiology | 1.60161129 |
49 | MP0002896_abnormal_bone_mineralization | 1.58935959 |
50 | MP0010352_gastrointestinal_tract_polyps | 1.58628866 |
51 | MP0000759_abnormal_skeletal_muscle | 1.57434182 |
52 | MP0001730_embryonic_growth_arrest | 1.57090003 |
53 | MP0002106_abnormal_muscle_physiology | 1.56460438 |
54 | MP0004185_abnormal_adipocyte_glucose | 1.56329891 |
55 | MP0002078_abnormal_glucose_homeostasis | 1.54421335 |
56 | MP0002118_abnormal_lipid_homeostasis | 1.52441475 |
57 | MP0005058_abnormal_lysosome_morphology | 1.51613006 |
58 | MP0010630_abnormal_cardiac_muscle | 1.48793945 |
59 | MP0005332_abnormal_amino_acid | 1.46722283 |
60 | MP0003566_abnormal_cell_adhesion | 1.43924126 |
61 | MP0002138_abnormal_hepatobiliary_system | 1.43411700 |
62 | MP0006054_spinal_hemorrhage | 1.41787089 |
63 | MP0008932_abnormal_embryonic_tissue | 1.39089876 |
64 | MP0009643_abnormal_urine_homeostasis | 1.38973535 |
65 | MP0010094_abnormal_chromosome_stability | 1.37826827 |
66 | MP0005369_muscle_phenotype | 1.36367053 |
67 | MP0003111_abnormal_nucleus_morphology | 1.32935710 |
68 | MP0002796_impaired_skin_barrier | 1.31849256 |
69 | MP0005375_adipose_tissue_phenotype | 1.30739642 |
70 | MP0005620_abnormal_muscle_contractility | 1.29331644 |
71 | MP0003567_abnormal_fetal_cardiomyocyte | 1.28617279 |
72 | MP0003984_embryonic_growth_retardation | 1.27631667 |
73 | MP0000579_abnormal_nail_morphology | 1.24900679 |
74 | MP0001672_abnormal_embryogenesis/_devel | 1.24205004 |
75 | MP0005380_embryogenesis_phenotype | 1.24205004 |
76 | MP0002088_abnormal_embryonic_growth/wei | 1.24080778 |
77 | MP0002837_dystrophic_cardiac_calcinosis | 1.22814567 |
78 | MP0008961_abnormal_basal_metabolism | 1.22197319 |
79 | MP0000762_abnormal_tongue_morphology | 1.21204555 |
80 | MP0005319_abnormal_enzyme/_coenzyme | 1.20495018 |
81 | MP0009703_decreased_birth_body | 1.18640515 |
82 | MP0003183_abnormal_peptide_metabolism | 1.17891545 |
83 | MP0002084_abnormal_developmental_patter | 1.17628955 |
84 | MP0010030_abnormal_orbit_morphology | 1.17187449 |
85 | MP0004130_abnormal_muscle_cell | 1.17161711 |
86 | MP0003191_abnormal_cellular_cholesterol | 1.16805085 |
87 | MP0002972_abnormal_cardiac_muscle | 1.16187751 |
88 | MP0001915_intracranial_hemorrhage | 1.16073868 |
89 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15738952 |
90 | MP0002108_abnormal_muscle_morphology | 1.15038965 |
91 | MP0004215_abnormal_myocardial_fiber | 1.13490707 |
92 | MP0005275_abnormal_skin_tensile | 1.12255484 |
93 | MP0005666_abnormal_adipose_tissue | 1.12012908 |
94 | MP0001756_abnormal_urination | 1.11160344 |
95 | MP0003077_abnormal_cell_cycle | 1.10287134 |
96 | MP0003172_abnormal_lysosome_physiology | 1.10101104 |
97 | MP0001697_abnormal_embryo_size | 1.09932788 |
98 | MP0008007_abnormal_cellular_replicative | 1.08562389 |
99 | MP0002086_abnormal_extraembryonic_tissu | 1.08112535 |
100 | MP0004197_abnormal_fetal_growth/weight/ | 1.07826239 |
101 | MP0000350_abnormal_cell_proliferation | 1.06254466 |
102 | MP0002928_abnormal_bile_duct | 1.05623270 |
103 | MP0003045_fibrosis | 1.05621914 |
104 | MP0008877_abnormal_DNA_methylation | 1.05409538 |
105 | MP0000750_abnormal_muscle_regeneration | 1.03264868 |
106 | MP0002085_abnormal_embryonic_tissue | 1.01637736 |
107 | MP0000428_abnormal_craniofacial_morphol | 1.00733554 |
108 | MP0006138_congestive_heart_failure | 1.00615880 |
109 | MP0001765_abnormal_ion_homeostasis | 0.99843980 |
110 | MP0010307_abnormal_tumor_latency | 0.98293703 |
111 | MP0002697_abnormal_eye_size | 0.98084604 |
112 | MP0008058_abnormal_DNA_repair | 0.98036924 |
113 | MP0005623_abnormal_meninges_morphology | 0.96668385 |
114 | MP0002080_prenatal_lethality | 0.96575555 |
115 | MP0005257_abnormal_intraocular_pressure | 0.94972737 |
116 | MP0010386_abnormal_urinary_bladder | 0.94424259 |
117 | MP0000604_amyloidosis | 0.93515078 |
118 | MP0002168_other_aberrant_phenotype | 0.93045827 |
119 | MP0003303_peritoneal_inflammation | 0.92197940 |
120 | MP0003937_abnormal_limbs/digits/tail_de | 0.92120367 |
121 | MP0000598_abnormal_liver_morphology | 0.90144389 |
122 | MP0005334_abnormal_fat_pad | 0.87129284 |
123 | MP0005248_abnormal_Harderian_gland | 0.85975059 |
124 | MP0009384_cardiac_valve_regurgitation | 0.85462291 |
125 | MP0003718_maternal_effect | 0.84814404 |
126 | MP0000266_abnormal_heart_morphology | 0.83004208 |
127 | MP0004272_abnormal_basement_membrane | 0.82738751 |
128 | MP0003959_abnormal_lean_body | 0.81629561 |
129 | MP0003385_abnormal_body_wall | 0.81491841 |
130 | MP0002971_abnormal_brown_adipose | 0.81117600 |
131 | MP0009672_abnormal_birth_weight | 0.80795737 |
132 | MP0010368_abnormal_lymphatic_system | 0.80576148 |
133 | MP0001544_abnormal_cardiovascular_syste | 0.80011572 |
134 | MP0005385_cardiovascular_system_phenoty | 0.80011572 |
135 | MP0005023_abnormal_wound_healing | 0.77109235 |
136 | MP0002009_preneoplasia | 0.76955897 |
137 | MP0005448_abnormal_energy_balance | 0.76623437 |
138 | MP0002295_abnormal_pulmonary_circulatio | 0.76554002 |
139 | MP0000432_abnormal_head_morphology | 0.76428868 |
140 | MP0002269_muscular_atrophy | 0.75882713 |
141 | MP0005187_abnormal_penis_morphology | 0.75787901 |
142 | MP0004019_abnormal_vitamin_homeostasis | 0.74942006 |
143 | MP0003953_abnormal_hormone_level | 0.74795976 |
144 | MP0005501_abnormal_skin_physiology | 0.74378028 |
145 | MP0001849_ear_inflammation | 0.73130839 |
146 | MP0005670_abnormal_white_adipose | 0.72896994 |
147 | MP0000747_muscle_weakness | 0.71966095 |
148 | MP0000569_abnormal_digit_pigmentation | 0.71013942 |
149 | MP0005636_abnormal_mineral_homeostasis | 0.70547630 |
150 | MP0002925_abnormal_cardiovascular_devel | 0.70161432 |
151 | MP0002060_abnormal_skin_morphology | 0.69580859 |
152 | MP0001881_abnormal_mammary_gland | 0.69433107 |
153 | MP0005535_abnormal_body_temperature | 0.67698220 |
154 | MP0001299_abnormal_eye_distance/ | 0.67373901 |
155 | MP0009642_abnormal_blood_homeostasis | 0.66265458 |
156 | MP0005408_hypopigmentation | 0.65849680 |
157 | MP0003329_amyloid_beta_deposits | 0.65773688 |
158 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65253110 |
159 | MP0005379_endocrine/exocrine_gland_phen | 0.61713204 |
160 | MP0002234_abnormal_pharynx_morphology | 0.60700166 |
161 | MP0004947_skin_inflammation | 0.59200462 |
162 | MP0000462_abnormal_digestive_system | 0.58841194 |
163 | MP0003795_abnormal_bone_structure | 0.58277080 |
164 | MP0003091_abnormal_cell_migration | 0.58221380 |
165 | MP0004087_abnormal_muscle_fiber | 0.57587211 |
166 | MP0000613_abnormal_salivary_gland | 0.57512371 |
167 | MP0000733_abnormal_muscle_development | 0.57449987 |
168 | MP0000678_abnormal_parathyroid_gland | 0.56900482 |
169 | MP0003656_abnormal_erythrocyte_physiolo | 0.55902782 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nemaline bodies (HP:0003798) | 6.95493056 |
2 | Muscle fiber inclusion bodies (HP:0100299) | 6.60041093 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.59367866 |
4 | Exercise-induced muscle cramps (HP:0003710) | 5.21185758 |
5 | Exercise-induced myalgia (HP:0003738) | 4.25426208 |
6 | Distal arthrogryposis (HP:0005684) | 4.22614773 |
7 | Hypoglycemic coma (HP:0001325) | 4.20622087 |
8 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.11570458 |
9 | Deep venous thrombosis (HP:0002625) | 4.07466960 |
10 | Intrahepatic cholestasis (HP:0001406) | 4.01638543 |
11 | Hypoglycemic seizures (HP:0002173) | 3.96083302 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 3.88651691 |
13 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70178056 |
14 | Hyperglycemia (HP:0003074) | 3.60133941 |
15 | Xanthomatosis (HP:0000991) | 3.54609604 |
16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.48116920 |
17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.44465030 |
18 | Ketoacidosis (HP:0001993) | 3.41194529 |
19 | Rimmed vacuoles (HP:0003805) | 3.31938868 |
20 | Round ear (HP:0100830) | 3.30364477 |
21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.28904062 |
22 | Calf muscle hypertrophy (HP:0008981) | 3.16557122 |
23 | Right ventricular cardiomyopathy (HP:0011663) | 3.14589714 |
24 | Calcaneovalgus deformity (HP:0001848) | 3.11638837 |
25 | Symptomatic seizures (HP:0011145) | 3.10065522 |
26 | Complement deficiency (HP:0004431) | 3.02277533 |
27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.00398873 |
28 | Ketosis (HP:0001946) | 3.00149264 |
29 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.91886617 |
30 | Subaortic stenosis (HP:0001682) | 2.90811752 |
31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.90811752 |
32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.88918501 |
33 | Neck muscle weakness (HP:0000467) | 2.87247890 |
34 | Skin nodule (HP:0200036) | 2.86249528 |
35 | EMG: myopathic abnormalities (HP:0003458) | 2.85941837 |
36 | Deformed tarsal bones (HP:0008119) | 2.81612655 |
37 | Mucopolysacchariduria (HP:0008155) | 2.81061599 |
38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81061599 |
39 | Increased connective tissue (HP:0009025) | 2.80910906 |
40 | Abnormality of the calf musculature (HP:0001430) | 2.76237149 |
41 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.75107791 |
42 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.73336392 |
43 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.73336392 |
44 | Myopathic facies (HP:0002058) | 2.71830008 |
45 | Fat malabsorption (HP:0002630) | 2.68555880 |
46 | Conjugated hyperbilirubinemia (HP:0002908) | 2.64834529 |
47 | Ulnar deviation of the wrist (HP:0003049) | 2.64498411 |
48 | Rhabdomyolysis (HP:0003201) | 2.62264110 |
49 | Late onset (HP:0003584) | 2.61965485 |
50 | Hypobetalipoproteinemia (HP:0003563) | 2.58575845 |
51 | Myoglobinuria (HP:0002913) | 2.55809162 |
52 | Back pain (HP:0003418) | 2.54828812 |
53 | Muscle fiber splitting (HP:0003555) | 2.54599064 |
54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.54281714 |
55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.54281714 |
56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.54281714 |
57 | Breech presentation (HP:0001623) | 2.52975823 |
58 | Epidermoid cyst (HP:0200040) | 2.51204515 |
59 | Abnormality of the calcaneus (HP:0008364) | 2.48572290 |
60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.48378018 |
61 | Hyporeflexia of lower limbs (HP:0002600) | 2.46738167 |
62 | Myocardial infarction (HP:0001658) | 2.42625999 |
63 | Shoulder girdle muscle weakness (HP:0003547) | 2.40626417 |
64 | Spinal rigidity (HP:0003306) | 2.38563021 |
65 | Protuberant abdomen (HP:0001538) | 2.37381777 |
66 | Prolonged partial thromboplastin time (HP:0003645) | 2.36487553 |
67 | Dysostosis multiplex (HP:0000943) | 2.36262111 |
68 | Abnormality of purine metabolism (HP:0004352) | 2.35865322 |
69 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.33358010 |
70 | Ventricular tachycardia (HP:0004756) | 2.32475074 |
71 | Difficulty running (HP:0009046) | 2.31604693 |
72 | Biliary tract neoplasm (HP:0100574) | 2.30473644 |
73 | Aneurysm (HP:0002617) | 2.29367823 |
74 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.28588688 |
75 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.27571614 |
76 | Papillary thyroid carcinoma (HP:0002895) | 2.27264188 |
77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.25968853 |
78 | Hypolipoproteinemia (HP:0010981) | 2.24372684 |
79 | Hypoalphalipoproteinemia (HP:0003233) | 2.23451102 |
80 | Abnormality of complement system (HP:0005339) | 2.21931247 |
81 | Gout (HP:0001997) | 2.20273779 |
82 | Sudden death (HP:0001699) | 2.19713124 |
83 | Turricephaly (HP:0000262) | 2.19674833 |
84 | Embryonal renal neoplasm (HP:0011794) | 2.18881806 |
85 | Hyperlipoproteinemia (HP:0010980) | 2.18110522 |
86 | Macroorchidism (HP:0000053) | 2.17515206 |
87 | Cerebral aneurysm (HP:0004944) | 2.12487664 |
88 | Popliteal pterygium (HP:0009756) | 2.11597789 |
89 | Limb-girdle muscle weakness (HP:0003325) | 2.08804932 |
90 | Hypoplastic ischia (HP:0003175) | 2.07417219 |
91 | Insulin resistance (HP:0000855) | 2.06277375 |
92 | Abdominal distention (HP:0003270) | 2.03407759 |
93 | Pterygium (HP:0001059) | 2.03232450 |
94 | Hepatocellular carcinoma (HP:0001402) | 2.03174261 |
95 | Abnormality of the ischium (HP:0003174) | 2.02710650 |
96 | Protrusio acetabuli (HP:0003179) | 2.02241162 |
97 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.01721319 |
98 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.01721319 |
99 | Pelvic girdle muscle weakness (HP:0003749) | 2.00509318 |
100 | Global brain atrophy (HP:0002283) | 2.00438682 |
101 | Thoracolumbar scoliosis (HP:0002944) | 1.99128559 |
102 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98624417 |
103 | Retinal atrophy (HP:0001105) | 1.96858420 |
104 | Rhabdomyosarcoma (HP:0002859) | 1.96735177 |
105 | Bundle branch block (HP:0011710) | 1.95233594 |
106 | Progressive external ophthalmoplegia (HP:0000590) | 1.94889035 |
107 | Distal lower limb muscle weakness (HP:0009053) | 1.94126207 |
108 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93078735 |
109 | Muscle stiffness (HP:0003552) | 1.88809553 |
110 | Malignant hyperthermia (HP:0002047) | 1.88233191 |
111 | Cortical dysplasia (HP:0002539) | 1.88119000 |
112 | Neoplasm of the small intestine (HP:0100833) | 1.87493162 |
113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87344740 |
114 | Osteolytic defects of the hand bones (HP:0009699) | 1.87344740 |
115 | Sensorimotor neuropathy (HP:0007141) | 1.86960249 |
116 | Long toe (HP:0010511) | 1.86390729 |
117 | Mitral stenosis (HP:0001718) | 1.85933216 |
118 | Abnormal delivery (HP:0001787) | 1.85705467 |
119 | Ankle contracture (HP:0006466) | 1.84739642 |
120 | Cervical subluxation (HP:0003308) | 1.84336100 |
121 | Abnormal cartilage morphology (HP:0002763) | 1.84159055 |
122 | Slender build (HP:0001533) | 1.81949911 |
123 | Hyperglycinuria (HP:0003108) | 1.81657182 |
124 | Metaphyseal cupping (HP:0003021) | 1.81484694 |
125 | Agitation (HP:0000713) | 1.81320099 |
126 | Hyperammonemia (HP:0001987) | 1.81103576 |
127 | Absent phalangeal crease (HP:0006109) | 1.80843917 |
128 | Hyperglycinemia (HP:0002154) | 1.80593826 |
129 | Ankyloglossia (HP:0010296) | 1.80007052 |
130 | Abnormal gallbladder morphology (HP:0012437) | 1.79524975 |
131 | Premature rupture of membranes (HP:0001788) | 1.79431872 |
132 | Flat acetabular roof (HP:0003180) | 1.79413703 |
133 | Hand muscle atrophy (HP:0009130) | 1.78289868 |
134 | Dilated cardiomyopathy (HP:0001644) | 1.77153633 |
135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77132510 |
136 | Lipoatrophy (HP:0100578) | 1.77018180 |
137 | Multiple enchondromatosis (HP:0005701) | 1.76835649 |
138 | Mitral valve prolapse (HP:0001634) | 1.76697707 |
139 | Metatarsus adductus (HP:0001840) | 1.76123276 |
140 | Progressive muscle weakness (HP:0003323) | 1.74843826 |
141 | Abnormal pancreas size (HP:0012094) | 1.74710302 |
142 | Increased nuchal translucency (HP:0010880) | 1.74632743 |
143 | Large for gestational age (HP:0001520) | 1.74243401 |
144 | Distal upper limb amyotrophy (HP:0007149) | 1.74234362 |
145 | Upper limb amyotrophy (HP:0009129) | 1.74234362 |
146 | Neoplasm of the rectum (HP:0100743) | 1.74042265 |
147 | Abnormal tarsal ossification (HP:0008369) | 1.74024024 |
148 | Hepatoblastoma (HP:0002884) | 1.74012975 |
149 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.73675876 |
150 | Gastrointestinal carcinoma (HP:0002672) | 1.73675876 |
151 | Lower limb amyotrophy (HP:0007210) | 1.73642228 |
152 | Colon cancer (HP:0003003) | 1.73266906 |
153 | Subacute progressive viral hepatitis (HP:0006572) | 1.73129260 |
154 | Limb-girdle muscle atrophy (HP:0003797) | 1.72589837 |
155 | Scapular winging (HP:0003691) | 1.71182908 |
156 | Hydroxyprolinuria (HP:0003080) | 1.71173066 |
157 | Abnormality of proline metabolism (HP:0010907) | 1.71173066 |
158 | Exostoses (HP:0100777) | 1.71136579 |
159 | Elevated alkaline phosphatase (HP:0003155) | 1.70880472 |
160 | Esophageal varix (HP:0002040) | 1.70226741 |
161 | Unilateral renal agenesis (HP:0000122) | 1.69828933 |
162 | Distal lower limb amyotrophy (HP:0008944) | 1.69623785 |
163 | Abnormal foot bone ossification (HP:0010675) | 1.69031735 |
164 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68813513 |
165 | Exocrine pancreatic insufficiency (HP:0001738) | 1.68330227 |
166 | Abnormality of nucleobase metabolism (HP:0010932) | 1.67836520 |
167 | Microglossia (HP:0000171) | 1.67231127 |
168 | Severe short stature (HP:0003510) | 1.66432061 |
169 | Steatorrhea (HP:0002570) | 1.66023299 |
170 | Enlarged penis (HP:0000040) | 1.65720262 |
171 | Abnormality of glycine metabolism (HP:0010895) | 1.65374241 |
172 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.65374241 |
173 | Joint hemorrhage (HP:0005261) | 1.65042472 |
174 | Hyperbilirubinemia (HP:0002904) | 1.64852611 |
175 | Thin bony cortex (HP:0002753) | 1.64082346 |
176 | Type 1 muscle fiber predominance (HP:0003803) | 1.63692366 |
177 | Abnormality of the salivary glands (HP:0010286) | 1.63475558 |
178 | Arterial tortuosity (HP:0005116) | 1.62867893 |
179 | Spastic diplegia (HP:0001264) | 1.62765872 |
180 | Asymmetric septal hypertrophy (HP:0001670) | 1.61565780 |
181 | Overgrowth (HP:0001548) | 1.58936543 |
182 | Trismus (HP:0000211) | 1.58734998 |
183 | Atrophic scars (HP:0001075) | 1.57422046 |
184 | Hyperkalemia (HP:0002153) | 1.57109876 |
185 | Amniotic constriction ring (HP:0009775) | 1.55952076 |
186 | Abnormality of placental membranes (HP:0011409) | 1.55952076 |
187 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.55938240 |
188 | Uterine neoplasm (HP:0010784) | 1.55875646 |
189 | Vascular tortuosity (HP:0004948) | 1.55778674 |
190 | Wide nose (HP:0000445) | 1.55399848 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 4.70153518 |
2 | ERN1 | 4.42890977 |
3 | TAOK3 | 4.22621283 |
4 | TRIB3 | 3.93631092 |
5 | LATS1 | 2.98653727 |
6 | TTK | 2.90876306 |
7 | FRK | 2.80242362 |
8 | INSRR | 2.80059528 |
9 | PKN2 | 2.73263125 |
10 | NEK1 | 2.65708294 |
11 | EIF2AK3 | 2.48397743 |
12 | MAP3K2 | 2.39450919 |
13 | SIK1 | 2.32017509 |
14 | PBK | 2.26197101 |
15 | TSSK6 | 2.22547949 |
16 | PTK6 | 2.18473212 |
17 | PDGFRA | 2.04730872 |
18 | PRKD3 | 1.98493628 |
19 | STK38L | 1.91540687 |
20 | SCYL2 | 1.81046209 |
21 | TAF1 | 1.79451230 |
22 | RIPK1 | 1.77866873 |
23 | MST4 | 1.66862923 |
24 | STK24 | 1.65822590 |
25 | IRAK3 | 1.62691817 |
26 | CDC7 | 1.59062367 |
27 | BCKDK | 1.54852171 |
28 | PTK2 | 1.47758648 |
29 | PNCK | 1.44515240 |
30 | EIF2AK1 | 1.43227930 |
31 | AKT3 | 1.42372915 |
32 | PHKG1 | 1.41488891 |
33 | PHKG2 | 1.41488891 |
34 | MAP3K1 | 1.39930071 |
35 | PLK3 | 1.36774421 |
36 | FGFR4 | 1.35363888 |
37 | BRSK2 | 1.32606974 |
38 | MKNK1 | 1.32497399 |
39 | CAMK1D | 1.30874845 |
40 | KSR2 | 1.30505895 |
41 | RET | 1.30282319 |
42 | PASK | 1.29925670 |
43 | MAP3K10 | 1.29237481 |
44 | CDK12 | 1.28181067 |
45 | HIPK2 | 1.25942603 |
46 | CAMK1G | 1.24966548 |
47 | PIK3CG | 1.21698404 |
48 | NLK | 1.20424111 |
49 | FLT3 | 1.19376535 |
50 | TTN | 1.19293910 |
51 | JAK1 | 1.14145395 |
52 | NEK9 | 1.11151704 |
53 | PRKCH | 1.10591537 |
54 | JAK2 | 1.09121602 |
55 | ERBB4 | 1.07835327 |
56 | DDR2 | 1.07298413 |
57 | TRPM7 | 1.06295282 |
58 | MET | 1.06279536 |
59 | MAP3K3 | 1.04402100 |
60 | SRPK1 | 1.03425994 |
61 | BUB1 | 1.03068969 |
62 | MTOR | 1.02793229 |
63 | PDK2 | 1.02251584 |
64 | TNIK | 0.97891501 |
65 | EPHB1 | 0.95979473 |
66 | PAK3 | 0.95159777 |
67 | STK3 | 0.93906195 |
68 | MKNK2 | 0.93822852 |
69 | SMG1 | 0.92870760 |
70 | PAK4 | 0.91747234 |
71 | FGFR3 | 0.91715420 |
72 | NTRK1 | 0.90132990 |
73 | MAP2K3 | 0.89231842 |
74 | CDK6 | 0.88153039 |
75 | PLK4 | 0.88100279 |
76 | FER | 0.88078180 |
77 | EEF2K | 0.87619889 |
78 | MAP3K9 | 0.87216621 |
79 | PDGFRB | 0.86321085 |
80 | CDC42BPA | 0.85723190 |
81 | WNK4 | 0.85295791 |
82 | LRRK2 | 0.83069263 |
83 | RPS6KB2 | 0.81890232 |
84 | ERBB3 | 0.81855531 |
85 | PLK1 | 0.79415030 |
86 | MYLK | 0.79341439 |
87 | EPHA3 | 0.77544243 |
88 | MAP2K4 | 0.76751151 |
89 | TAOK1 | 0.76196471 |
90 | DYRK3 | 0.74238739 |
91 | NME1 | 0.72817814 |
92 | CHEK1 | 0.72815079 |
93 | NEK2 | 0.70852319 |
94 | TIE1 | 0.70383507 |
95 | PRKAA1 | 0.69119737 |
96 | CAMKK1 | 0.68888350 |
97 | BMX | 0.68818372 |
98 | SGK3 | 0.68208796 |
99 | EPHA2 | 0.67794364 |
100 | ALK | 0.66144934 |
101 | ATM | 0.64264754 |
102 | BRAF | 0.63824524 |
103 | ACVR1B | 0.63490201 |
104 | MAP3K8 | 0.62892131 |
105 | MAP2K1 | 0.62765424 |
106 | DMPK | 0.61942001 |
107 | EIF2AK2 | 0.61816442 |
108 | PAK2 | 0.59406268 |
109 | WNK1 | 0.59113492 |
110 | MAP3K5 | 0.57960795 |
111 | MAP3K7 | 0.57679791 |
112 | GSK3A | 0.57577454 |
113 | LATS2 | 0.57343215 |
114 | BRD4 | 0.57256770 |
115 | FGFR1 | 0.56740921 |
116 | PDPK1 | 0.56530650 |
117 | MST1R | 0.55083598 |
118 | AKT2 | 0.53912317 |
119 | PRKD1 | 0.52928839 |
120 | DYRK1B | 0.51342531 |
121 | JAK3 | 0.51169894 |
122 | CSNK1E | 0.50898274 |
123 | STK10 | 0.50461474 |
124 | PRKAA2 | 0.50119540 |
125 | TYK2 | 0.49380910 |
126 | TGFBR1 | 0.48849905 |
127 | CDK7 | 0.48833727 |
128 | CDK19 | 0.47316297 |
129 | AURKB | 0.47112477 |
130 | MAP3K12 | 0.46379383 |
131 | WEE1 | 0.44944275 |
132 | YES1 | 0.44934622 |
133 | PRKDC | 0.43861689 |
134 | TGFBR2 | 0.43509990 |
135 | CHEK2 | 0.43381507 |
136 | FGFR2 | 0.43356306 |
137 | STK4 | 0.42720698 |
138 | EGFR | 0.42175443 |
139 | NUAK1 | 0.41348197 |
140 | MAP2K2 | 0.40950958 |
141 | ICK | 0.40879104 |
142 | PRKG2 | 0.40273533 |
143 | BCR | 0.39960574 |
144 | KSR1 | 0.38570970 |
145 | MAPK11 | 0.38071024 |
146 | PDK1 | 0.37952726 |
147 | MAPK15 | 0.37666552 |
148 | RPS6KA2 | 0.35925987 |
149 | MAP3K6 | 0.35041338 |
150 | IGF1R | 0.33656713 |
151 | ABL2 | 0.33392503 |
152 | CDK9 | 0.32242434 |
153 | PRKD2 | 0.31923865 |
154 | PRKACG | 0.30423365 |
155 | RPS6KB1 | 0.29408840 |
156 | CHUK | 0.29370323 |
157 | ERBB2 | 0.28421978 |
158 | MELK | 0.27997723 |
159 | IRAK1 | 0.27888500 |
160 | ZAP70 | 0.27239960 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.34301088 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31580648 |
3 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.62541784 |
4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.54836052 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.50098143 |
6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.36083979 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.26041764 |
8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.23756162 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.22889859 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20441263 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99599570 |
12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.98082339 |
13 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.94831245 |
14 | Mismatch repair_Homo sapiens_hsa03430 | 1.80434017 |
15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73568246 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71775182 |
17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69430512 |
18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66741762 |
19 | RNA transport_Homo sapiens_hsa03013 | 1.63729363 |
20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.62121038 |
21 | Protein export_Homo sapiens_hsa03060 | 1.59054861 |
22 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.57350697 |
23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.55760716 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50343035 |
25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42778787 |
26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.39454710 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.39298524 |
28 | Cell cycle_Homo sapiens_hsa04110 | 1.38248282 |
29 | Bile secretion_Homo sapiens_hsa04976 | 1.37140074 |
30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.35884268 |
31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35714901 |
32 | Insulin resistance_Homo sapiens_hsa04931 | 1.35486290 |
33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.35386761 |
34 | Tight junction_Homo sapiens_hsa04530 | 1.34736713 |
35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34718048 |
36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.31531419 |
37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30792886 |
38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26797003 |
39 | DNA replication_Homo sapiens_hsa03030 | 1.26667036 |
40 | Lysine degradation_Homo sapiens_hsa00310 | 1.17286946 |
41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.16939829 |
42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.16535291 |
43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16489825 |
44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.12281003 |
45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10336784 |
46 | Insulin secretion_Homo sapiens_hsa04911 | 1.09313879 |
47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.08732722 |
48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07652665 |
49 | ABC transporters_Homo sapiens_hsa02010 | 1.06864813 |
50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06325156 |
51 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05849292 |
52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03291518 |
53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01181163 |
54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97702654 |
55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96035070 |
56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95747808 |
57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94188049 |
58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92617617 |
59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91661483 |
60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90416225 |
61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89294752 |
62 | Lysosome_Homo sapiens_hsa04142 | 0.89281976 |
63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88146485 |
64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87860874 |
65 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87738161 |
66 | Peroxisome_Homo sapiens_hsa04146 | 0.85192989 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85150541 |
68 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.84099799 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.83917469 |
70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78533244 |
71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78321282 |
72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78127486 |
73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76447212 |
74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75738096 |
75 | Bladder cancer_Homo sapiens_hsa05219 | 0.73396960 |
76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72712138 |
77 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.72085769 |
78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71126060 |
79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71082141 |
80 | RNA degradation_Homo sapiens_hsa03018 | 0.70974577 |
81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69872984 |
82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.69780095 |
83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69144107 |
84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67938870 |
85 | Amoebiasis_Homo sapiens_hsa05146 | 0.67513476 |
86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66474166 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65636940 |
88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65515317 |
89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64276461 |
90 | Spliceosome_Homo sapiens_hsa03040 | 0.63912793 |
91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63878118 |
92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61918563 |
93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61780722 |
94 | Adherens junction_Homo sapiens_hsa04520 | 0.61289526 |
95 | Focal adhesion_Homo sapiens_hsa04510 | 0.61056847 |
96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60261452 |
97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59916347 |
98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59912672 |
99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59777259 |
100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59575186 |
101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59017077 |
102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58751007 |
103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56750271 |
104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56739449 |
105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56638515 |
106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56549259 |
107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56367762 |
108 | Prostate cancer_Homo sapiens_hsa05215 | 0.56185020 |
109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56025377 |
110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55226177 |
111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51596074 |
112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51439178 |
113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51390634 |
114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51166322 |
115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49840103 |
116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49548497 |
117 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48462177 |
118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48023482 |
119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47937691 |
120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47003845 |
121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46282001 |
122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45872049 |
123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45449460 |
124 | Melanoma_Homo sapiens_hsa05218 | 0.45235224 |
125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44936666 |
126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44396259 |
127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44267393 |
128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43525244 |
129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42504257 |
130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42111933 |
131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41680700 |
132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39773384 |
133 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37046548 |
134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36422823 |
135 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35624140 |
136 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35299096 |
137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34624835 |
138 | Glioma_Homo sapiens_hsa05214 | 0.34161425 |
139 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34125852 |
140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.33889339 |
141 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32722403 |
142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32494406 |
143 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31154703 |
144 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30390913 |
145 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29653053 |